Metabolism of Arsenic in Human by AS3MT Gene

Metabolism of Arsenic in Human by AS3MT Gene | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Metabolism of Arsenic in Human by AS3MT Gene Pratik V. Malvade, Mayur S. Bhosale, Sayli R. Chavan, Dhanashri Bhagat This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-1320965/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract The AS3MT may be a most significant protein for the methylation of chemical elements species. The transfer of methyl radical from S-adenosyl-L-methionine (AdoMet) to powerfulness arsenical (AsIII) is catalyzed by the AS3MT that is critical for arsenic metabolism in humans. Since genetic polymorphisam of AS3MT is related to arsenic tolerance, here investigate co-relationship in between single ester polymorphisms (SNPs) in AS3MT with inorganic arsenic (iAs) metabolism. additionally we tend to compared chemical action properties of recombinant human AS3MT and AS3MT/M287T in reaction mixtures containing S-adenosylmethionine, arsenite (iAsIII) or methylarsonous acid (MAsIII) as substrates and endogenous reductants, together with glutathione (GSH), a thioredoxin enzyme (TR) or thioredoxin (Trx) or NADPH reducing system and tris(2-carboxyethyl) pesticide complex (TCEP). By victimisation of either TR or Trx or NADPH or TCEP, AS3MT catalyzes the conversion of iAsIII to MAsIII then to methyl radicalarsonic acid (MAsV), dimethylarsinous acid (DMAsIII) and di ethylarsinic acid (DMAsV). The Cys156 and Cys206 gift in similarity model forms the binding website for AsIII. Cys32 and Cys61 forms a disulphide bond. the most important product in initiative of methylation is MAsIII that remains sure to protein until it get methylated. The product are the a lot of hepatotoxic and more malignant neoplastic disease powerfulness methyl arsenicals, however arsenic undergoes oxidisation and reduction as enzyme-bound intermediates. Genetic Mutation Arsenic Metabolism AS3MT MAsIII DMAsIII Figures Figure 1 Figure 2 Figure 3 Figure 4 Introduction As humans get evaluated they get custom-made to the surrounding environment. The adaption happens i.e. mutation [1,2] . Mutation allows organisms to metabolize toxic things [3] . The peoples can still metabolise low level. Scientists found that due to more consumption of arsenic water, the body has developed a genetic ability to metabolize arsenic. Scientists found that peoples of Andes can do metabolism arsenic. [4] . Arsenic can comeinbody from drinking water sources such as Inorganic Arsenic (iAs) in As III or As V i.e. arsenite or arsenate [5,6] . The As III (Arsenite) species are AsO 3 - , HAsO 3 2− , H 2 AsO 3 − and H 3 AsO 3 , while As V (Arsenate) species are: AsO 4 III− , HAsO 4 2− , H 2 AsO 4 − and H 3 AsO 4 . Group I type compounds i.e. inorganic arsenic [7] . The safe levelof arsenic indrinking water is 10 µg/L as per WHO [8] . High arsenic exposure can show effects like skin pigmentation, hyperkeratosis, and cancer of bladder, liver, and kidney which may cause deaths [9, 10] . The arsenic metabolises by dual pathways, which are oxidative methylation and reductive methylation. During metabolism arsenic transformed to Methylarsenite (MAs III ), Dimenthylarsenite (DMAs III ), and sometimesmaybee to Trimethylarsine (TMAs III ) by the enzyme As III S-adenosylmethionine methyltransferase (SAM) [11,12] . In the gastrointestinal tract the Methylarsenite (MAs III ), Dimenthylarsenite (DMAs III ) are get methylated to form Monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). MMA and DMA are less toxic than both MAs III and DMAs III so they are readily excreted through urine, where they get oxidized abiotically to MAs V and DMAs V [13] . When the MAs V and DMAs V levels increase in the urine is an indication of Arsenic related diseases [14] . The distribution of arsenic metabolites in urine is 10–30% iAs, 0-11% MAs and 26-30% DMAs, but this distribution can vary from individual to individual [15] . Single Nucleotide Polymorphisms in the hAS3MT gene are linked. Most SNPs have little effect on health, however the M287T SNP in hAS3MT can cause cancer and skin issues [16,17] . When methylation of inorganic arsenic occurs it produces toxic compound than previous [18] . For example, one protective The AS3MT haplotype is prevalent in indigenous tribes in Argentina they consumed arsenic toxic water for long period. The concentration of arsenic in water is 0.8 mg/L and little urine excretion of MAs (7.5 %) and a greater percentage of DMAs (78 %). In this study, we reviewed the human genetic related to AS3MT to find out ability of enzymes to metabolise arsenic and the effect of amino acid substitution on it. Methylation of arsenic helps to prevent death and sever conditions. For this study, we synthesized the hAS3MT gene by bacterial synthesis, which helps us to get pure AS3MT for further study. Then we compare the properties of enzymes in between hAS3MT and AS3MT by using As III ionized molecule, which allows us to relate the structural and enzymatic property of both. In this, we show that AS3MT is essential for arsenic methylation capacity and present evidence that HGTs (Horizontal Gene Transformation) from prokaryotes to eukaryotes underlie adaptations to arsenic which is also known as mutation. In this study we discussed about how the animals get evaluated from last centuries [19] . Materials And Methods We declare that, all methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by a Pravara Rural College Of Pharmacy, Pravaranagar. All experiments were performed in accordance with relevant guidelines and regulations. Reagents Tris-(2-carboxyethyl)-phosphine (0.5 M, pH 7) was prepared. MAs V was reduced to trivalent MAs III using Na 2 S 2 O 3 , Na 2 S 2 O 5, and H 2 SO 4 and adjusted to pH 6.5 with NaOH [20] . High-Performance Liquid Chromatography (HPLC) coupled to inductively coupled mass spectroscopy validated the identities of the reduction products (ICP-MS). The methylation substrates were the Glutathione (GSH) conjugates As(GS) and MAs(GS), which were made by incubating 1 mM AsIII or MAsV with a four-fold molar excess of GSH in degassed buffers under argon for 5 hours at 23 °C. [21] . Strains & Growth Conditions For plasmid E. coli was used by (Dheeman D. S.; Packianathan C.). Bacterial growth was monitored by measuring the optical density at 600 nm (A 600nm ) [19] . Human AS3MT Gene Cloning of hAS3MT cDNA Chemically synthesized hAS3MT gene matching to the sequence of the cDNA clone, which lacks the final nine residues of the hAS3MT sequence, with codon optimization for expression in E. coli and sub-cloned into the EcoRV site of pUC57-Kan-hAS3MT. The synthetic hAS3MT gene was cloned into expression vector pMAL-c2x as an EcoRI/SalI digest from pUC57-Kan-hAS3MT, resulting in a fusion with the maltose-binding protein gene at the 5′ end and eight histidine residues at the 3′ end of the genomic sequence. The forward primer 5′-CCAGCCATGGCTGCACTTCGTGACGCTGAGA-3′ (NcoI site highlighted) and reverse primer 5′-CCTAGTCGACTCCAGCAGCATCAGGGACACATC-3′ were used to amplify the 1.1 kb fragment using PCR (SalI site underlined) [19,22] . Constructing Mutation Site-directed mutagenesis used to create mutations in the AS3MT gene. The conserved Cys32, Cys61, Cys156, and Cys206 residues were altered to serine codons, resulting in seven single-cysteine mutants of the synthetic hAS3MT. Commercial DNA sequencing verified each hAS3MT mutation. Expression and Purification of Protein By using the Ni-NTA chromatography Wild-type AS3MT (87 837 Da) and variant enzymes are purified by using E. coli [19] . Cells carrying the plasmid pET41a-hAS3MT were grown at 37 °C in 1 L of Luria Broth medium with 10 gm of tryptone, 5 gm of yeast extract, and 10 gm of NaCl per litre containing 50 g/mL Kanamycin for 3 hours before induction with 0.3 mM isopropyl -D-1-thiogalactopyranoside (IPTG) After centrifuging the induced culture at 5000 rpm for 15 minutes at 4 °C, it was suspended in 20 mL of buffer A containing 50 mM NaH2PO4 (pH 8.0), 1 mM TCEP, and 0.3 M NaCl, to which 10 mM imidazole was added. The cells were lysed in the presence of Di-isopropyl fluorophosphate using a press before being centrifuged at 35000 rpm for 1 hour. Then, apply the aforementioned solution (0.7 mL/min) to a Ni-NTA agarose column that has already been loaded with 5 column volumes of buffer. hAS3MT was then eluted (0.7 mL/min) with 8 column buffer containing 0.25 M Imidazole after being column washed (1 mL/min) with 10 of buffer containing 20 mM Imidazole. The Imidazole is then removed. As previously disclosed, natural hAS3MT was purified. Purify thioredoxin (Trx) and thioredoxin reductase (TR) from E. coli BL21(DE3) bearing either pET14b-trxA or pET14b-taxi using Ni-NTA chromatography as stated above. Before use, all buffers were degassed (aliquoted) by bubbling with argon for 30 minutes [19] . METABOLISM OF ARSENIC (AS3MT) There are two pathways by which the human body metabolize the arsenic compound i.e. Methylation by Oxidation and Reduction type of reaction The activity of AS3MTs was checked at 37 °C in a buffer of 50 mM NaH 2 PO 4 pH 8 & 0.3 M NaCl. The chemicals in the assay are 5 mM GSH, 1 mM SAM, 10 μM Trx, 3 μM TR, and 0.3 mM NADPH, and the reactions were terminated by adding 10% (v/v) H 2 O 2 to oxidize all arsenic species. Centrifugation using a 3 kDa cut-off Amicon ultra-filter was used to remove denatured protein. Then analysed by using HPLC. Oxidative Methylation This process is also called as bioactive process. This pathway is given by Cullen and Reimer. By the combination of Oxidative methylation, arsenate (As V ) is changed to Dimethylarsinous acid (DMA III ). Then Arsenate (As V ) gets converted into Arsenite (As III ) following to Monomethylarsonic acid (MMA V ) then it gets converted into Mono-methylarsonous acid (MMA III). Then MMA III converts into Dimethylarsinic acid (DMA V ) and finally it forms Dimethylarsinous acid (DMA III ). We can’t explain the complete metabolism process because of the detection of DMV V arsenic which occurs in a major amount in human urine. Because the toxicity of MMAV and DMAV is substantially lower than that of iAs, methylation is thought to be a detoxification step for iAs. According to several recent investigations, MMAIII or DMA III are more cytotoxic and genotoxic than iAs. [24,25] . We noticed that if we cannot add H 2 O 2 it allow us to determine trivalent arsenicals. Reductive Methylation This pathway of arsenic was proposed by Hayakawa et. al [26] . In this pathway, trivalent arsenicals are conjugated with glutathione (GSH) and then they get methylated. In the first step, As III changes to As III GS3 then MMA + 3GS2 is formed then later it gets reduced to Dimethylarsenoglutathione (DMA III GS) [As in Figure. 1(b)]. Then correspondingly the MMA + 3GS2 and DMA III GS are get oxidized to MMA V and DMA V . We investigated the renal metabolites and hepatic metabolites after giving the arsenic intravenously to the mice (0.5 mg/kg body weight), then we observed that when a trivalent species (As III ) of arsenic binds to a thiol group (R-SH) present in proteins. Then the protein-arsenical complex detaches from a parent protein and forms conjugation with Glutathione (GSH) to form As III (GS) 3 or MMA III (GS) 2 or DMA III (GS). Hence it is found that during reductive methylation MMA V and DMA V are the end products. But in this pathway, DMA V is in the major amount present in urine called as detoxification [27] . At the point when iAs is methylated through Oxidative and Reductive Methylation, the AS3MT quality assumes a basic part. AS3MT is an S-adenosyl-L-methionine-subordinate compound that can methylate trivalent arsenicals [28] . The human AS3MT gene is 32 kb long and has 11 exons. A variety of genetic variations SNP. A VNTR is a spot in DNA where a short nucleotide sequence is organized [28] . When AS3MT methylates inorganic arsenic, it can cause oxidative DNA damage and enhance their carcinogenicity. Assays of Arsenic Methylation To assay measurement of conversion of SAM to S-adenosylhomocysteine (SAH) EPI generous Methyltransferase Assay kit is used where the time-resolved Förster resonance energy transfer (TR-FRET) is used [ 30] . The test was completed utilizing a 384-well microtiter plate in a cushion comprising of 50 mM NaH2PO4 (pH 8.0), containing 0.3 M NaCl, 1 μM cleaned hAS3MT, 0.5 mM GSH, 1 μM Trx, 0.3 μM TR and 0.03 mM NADPH and 10 μM of As(GS) or MAs(GS). Then we added the SAM at 10 μM. The emission was 665:620 nm for determine Homogeneous Time-Resolved Fluorescence (HTRF). The concentration calculated as given in Fig. 2. [30] . For measurement, (HPLC) and for arsenic concentration Inductively Coupled Plasma Mass Spectrometry (ICP-MS) was used [19] . Then added the SAM to at 37°C. To recuperate the entirety of the arsenic, the responses were ended by the expansion of H2O2 at 10% (v/v) last fixation, which additionally oxidizes all arsenicals, so the items will be named MAs and DMAs. Speciation of arsenic in the still up in the air by HPLC with a C18 300A opposite stage section with the arsenic focus estimated by ICP-MS utilizing an ELAN 9000 ICP-MS. AsIII, MAIII, DMAV, MAV, and AsV were utilized at 1 μM as principles. E. coli cells expressing the genotype and mutants of the hAS3MT gene. Hence, we carried both methylation processes on them. The cells were grown for 12 hours at 37 °C in a 2 mL liquid broth medium of 0.3 mM Isopropyl-D-1-thiogalactopyranoside (IPTG), 100 g/mL kanamycin, and 10 M of AsIII or 2 M MAIII or both was used. The cells were extracted, washed, and suspended in ST-1 media with 2 M MAIII before being cultured at 37 °C for 3 hours. Arsenicals were speciated by HPLC using a C18 reverse phase column, and the quantity of arsenic was calculated by Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) (ICP-MS). HAS3MT STRUCTURE HOMOLOGY MODEL WITH POLYMORPHIC RESIDUES Using a fully automated protein structure homology modelling system, a homology model of hAS3MT was generated from residues on the structure of PhAsIII, which is confined to CmArsM. We utilize the PATCHDOCK server to find SAM's position in the model. The AsIII bound structure of CmArsM [32] was overlaid on the found hAS3MT model using SAM. We used a visual technique to get the arsenic atom in the AsIII binding site of hAS3MT. As seen in Fig. 3. The human AS3MT model structure is depicted in a cartoon diagram with a tan colour scheme. The Relationship between Arsenic Methylation and Genotypes in Human AS3MT In this study, we employ SNP, which stands for polymorphism identification number related to the consensus sequence site (AY817668), with the first base of the consensus number 1 and dbSNP rs# cluster id [29] . Figure 4 depicts the chromosomal positions of genetic polymorphisms in AS3MT. Out of all SNPs, three of them has non-synonymous exon region, which is Arg173Trp, Met287Thr, and Thr306Ile. When these AS3MT-expressing cells are treated with 12.5 nM AsIII, the Met287. During our study, we discovered that repeated sequences of 5'-UTR VNTR influences the transcriptional expression of gene. According to the findings of this study, polymorphisms in AS3MT lead to individual variability in AS3MT expression and function, as well as variance in the risk of arsenic-dependent carcinogenesis. ANIMAL CASE STUDY This study was conducted. The selected animals (mice’s) are treated with arsenic containing water in different concentrations. [34] Collection of different samples Groundwater sample collection We collected the water from 15 random groundwater wells in the polythene bottle which is previously treated with 25% HNO 3 for 3 hours. Then the bottles are washed with water. After sample were kept under refrigerated at the laboratory. Blood sample collection Blood samples from subjects were collected by venous puncture using lead-free vacutainer tubes containing EDTA as an anticoagulant. The blood was collected from all subjects and transferred to laboratory for study. DNA was extracted through the HP-PCR (High Pure-Polymerase Chain Reaction). Collection of a urine sample Approximately 15 ml of urine sample is collected bottle and the bottle is cleaned as mentioned in Groundwater is also collected. The sample was freeze to prevent oxidation. Then sample was filtered to remove unwanted waste. Risk Assessment The following calculation was used to assess human exposure to arsenic in groundwater using the Lifetime Average Daily Dose (LADD), which is the amount of daily arsenic exposed from one or more sources and is given in g of arsenic per kilogramme body weight per day (g/kg/day): Where, C - Arsenic concentration in water (µg/L), IR - The water intake rate per day (L/day), ED - Exposure duration (years), EF - The exposure frequency (days/year), Kg - The body weight/Kg, AT - The average time (day) By the LADD value we determined the Hazard Quotient (HQ) by the following equation; Where, RfD is reference dose for arsenic is 10 µg/kg/day as given by WHO for India to avoid non-cancerous outcomes such as hyperpigmentation, keratosis, and possible vascular complications. Determination of Groundwater Quality and Arsenic It was necessary to check turbidity, pH, conductivity, temperature, dissolved oxygen, chloride, fluoride, nitrite, nitrate, magnesium, and other physiochemical parameters. In the laboratory, chloride (mg/L) and fluoride (mg/L) were measured using a Benchtop Multiparameter pH/ISE with the appropriate ion-selective electrodes. Urinary Arsenic Species (UAs) determination by Instrumental Analysis Using HPLC-HG-AFS, the urinary arsenic species (UAS) (AsIII, AsV, MMA, and DMA) were determined (High-Performance Liquid Chromatography-Hydride Generation-Atomic Fluorescence Spectrometry). A Hamilton PRP-X100 anion-exchange column with a diameter of 250 mm aqueous buffer KH2PO4 or K2HPO4 with a pH of 5.8 is used as the mobile phase. The flow rate was 1.0 mL/min. To find out Total Urinary Arsenic, the urine sample is subjected within HNO3 and HClO4 to convert arsenic to inorganic arsenic (iAs). Finally, the HG-AFS method is employed to calculate UAs (Hydride Generation-Atomic Fluorescence Spectrometry). Quality Assurance for Arsenical Limit of detection (LOD) and limit of quantification (LOQ) were employed to detect arsenic in water, yielding values of 0.7 g/L and 1.2 g/L, respectively. The concentration of arsenic in urine is measured. We reported 106.22 g/L of total iAs, which is the sum of the AsIII and AsV. We also used HPLC-HG-AFS to verify the recovery of arsenic species, yielding a total of 107.8 2.4 g/L, which matched to 99.5 2.1 g/L of AsV and 8.3 0.3 g/L of DMA. The following were the Urinary Arsenic Species (UAS) Limits of Detection (LOD): AsIII is 0.17 g/L, AsV is 0.38 g/L, MMA is 0.30 g/L, and DMA is 0.45 g/L. STATISTICAL ANALYSIS Because arsenic concentrations in groundwater and urinary arsenic species do not have a normal distribution. The genotype distributions of GSTP1-rs1695, GSTO2-rs156697, and As3MT-rs3740400 were measured using the Hardy-Weinberg equilibrium (HWE). Allelic frequencies were obtained by dividing the frequencies of heterozygous and homozygous alleles by the total number of allelic variants. We split the total number of individuals into two groups: those with a low daily dosage (LADD 0.3 g/kg/day) and those with a high daily dose (LADD > 0.3 g/kg/day). We do the comparison between low and high exposure doses. To understand the differences between low and high intake of toxics, an effect size test was performed [37]. The polymorphisms and LADD were used as independent factors in the study, while urine arsenic species were used as dependent variables. The study included genetic dominant models (heterozygous + homozygous genotype) as well as possible confounders (age, BMI, smoking history, and lifestyle). With a stronger biological sense, dominant models over Potential Confounders model are explored in the research population. We used various factors to analyse the multi-collinearity of independent variables (VIF) [38] . Discussion During the transformation of arsenic, the conversion of inorganic arsenic to Methylarsonic acid and dimethylarsinic acid is the most important step [42] . On basis of metabolism processes of arsenic we was curious to find that is it is suitable to inhibit cancer or not [43] . The main step is to give annotation of the AS3MT gene, resulting in several differences from the current “provisional” NCBI annotation. During the re-sequencing, we identified 27 polymorphisms, including three non-synonymous cSNPs and a VNTR. For allozymes, Trp 173 and Ile 306 , levels of enzyme activity and immune-reactive protein were strikingly decreased when compared with the WT allozyme. [44,45,46] . All of the substituted residues are on the surface of the protein except for Thr306, which is buried inside the enzyme, so a T306I substitution is disrupt the structure (figure 3). The second methylation step is reduced when M287T SNP is occur [47] . Met287 is located on the surface of AS3MT where the molecular inhibitors bind [48] . We also see that when M287T substitutes the binding site it retards the allosteric conformational change and reduces the rate of methylation of this variant. This property is observed in individuals with the M287T polymorphism epidemiological studies. During the stability study in temperature, we found that the variants denature between 4 to 20 fold faster than wild-type hAS3MT. The protective AS3MT polymorphisms are located outside of the coding sequence regulatory elements. Results Methylation of arsenic is conversion from product to substrate [39,40] . The ratio of MAs/iAs is the primary methylation index, while the ratio of DMAs/MAs is the secondary methylation index (SMI). The SMI is primarily used to assess methylation capability in persons exposed to inorganic arsenic. [41] . We evaluated the methylation index of wild-type hAS3MT to that of eight polymorphic enzymes in this work. SMI and PMI were found to be lower in eight polymorphic enzymes. The greatest value of the DMAs/MAs ratio in wild-type enzymes is 2.3 0.3. M287T, R251H, and T306I SMI values (about 1.2) were lower than the wild-type enzyme but higher than the other SNPs, while the SMI values of H51R, I136T, and R173W enzymes were roughly 0.45. This research demonstrates that the eight non-synonymous missense variations of hAS3MT had a decreased arsenic methylation capacity when compared, implying that there is variance in arsenic methylation from individual to individual, which may raise the risk of arsenic-related disorders. Conclusion The gene-gene interactions As3MT*GSTM1 and GSTO2*GSTP1 were discovered to be possible regulators of urinary arsenic metabolites, increasing MMA and decreasing DMA, in this work. A synergistic effect of these polymorphisms and age, LADD of arsenic, and alcohol use may also alter a significant fraction of the population's arsenic individual metabolic capacity. Despite some discrepancies between genotypes and metabolism in human case studies, we discovered that two SNPs, AS3MT 12390 (rs3740393) in intron and 14458 (rs11191439, Met287Thr) in exon, vary across all nations, indicating that SNPs may be ethnically independent polymorphisms, but they can affect arsenic methylation. Argentina's population has a more proportion of DMA and a lower DM. This different distribution may have led to the findings that Argentina's population had a higher percentage of DMA and a lower percentage of MMA in the urine when compared to other research. It's worth looking into if the genotype distribution of AS3MT 12390 (rs3740393) is unique to this group (Argentinean Andes) and how this unique SNP selection happened. Abbreviations AS3MT - As III SAM methyltransferase As III - Arsenite DMAs III - Dimethylarsenite DMAs V - Dimethylarsenate ESP - Exome Sequencing Project GSH - Reduced glutathione LB Medium - Luria–Bertani medium VNTR - Variable Number of Tandem Repeats MAs III - Methylarsenite MAs V - Methylarsenate SAM - S-adenosylmethionine SAH - S-adenosylhomocysteine SNPs - Single nucleotide polymorphisms SMI - Secondary methylation index TMAs III -Trimethylarsine Trx - Thioredoxin TR - Thioredoxin reductase Declarations Acknowledgements We thank Prof. Mayur Bhosale for assistance with genetics, and Dr. Sanjay Bhawar, Principal, Pravara Rural College Of Pharmacy, Pravaranagar for comments that greatly improved the manuscript. Funding Info “The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.” Competing interests “The authors have no relevant financial or non-financial interests to disclose.” Ethics statement “This is an observational study. The Pravara Research Ethics Committee has confirmed that no ethical approval is required.” Consent to Participate (Ethics) Informed consent was obtained from all individual participants included in the study Consent to Publish (Ethics) The participant has consented to the submission of the case report to the journal. Author Contributions “All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Pratik V. Malvade, Mayur S. Bhosale, and Sayli R. Chavan. The first draft of the manuscript was written by Pratik V. Malvade and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.” Availability of data and material We do not wish to share our data before we have thoroughly analyzed it. All data sources described in the study are directed at the corresponding author. Data Availability Statement This article is a review article. So, data sharing not applicable to this article as no datasets were generated or analyzed during the current study References Melnick JG, Parkin G. Cleaving mercury-alkyl bonds: a functional model for mercury detoxification by MerB. Science. 2007; 317: 225–227. https://doi.org/10.1126/science.1144314 PMID: 17626880 Hanikenne M, Talke IN, Haydon MJ, Lanz C, Nolte A, Motte P, et al. Evolution of metal hyperaccumulation required cis-regulatory changes and triplication of HMA4. Nature. 2008; 453: 391–395. https://doi.org/10.1038/nature06877 PMID: 18425111 Najarro MA, Hackett JL, Smith BR, Highfill CA, King EG, Long AD, et al. Identifying loci contributing to natural variation in xenobiotic resistance in Drosophila. PLoS Genet. 2015; 11: e1005663. https://doi.org/10.1371/journal.pgen.1005663 PMID: 26619284 Richard Grey, Dailymail. https://www.dailymail.co.uk/sciencetech/article-2979234/The-people-eat-ARSENIC-Remote-village-Andes-developed-tolerence-toxic-chemical.html Caceres, D.D.; Pino, P.; Montesinos, N.; Atalah, E.; Amigo, H.; Loomis, D. Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population. Environ. Res. 2005, 98, 151–159 Caceres, D.D.; Werlinger, F.; Orellana, M.; Jara, M.; Rocha, R.; Alvarado, S.; Quiñones, L. Polymorphism of Glutathione S-Transferase (GST) variants and its effect on the distribution of urinary arsenic species in people exposed to low inorganic arsenic in tap water: An exploratory study. Arch. Environ. Occup. Health 2010, 65, 140–147. IARC (International Agency for Research on Cancer). Some drinking-water disinfectants and contaminants, including arsenic, IARC. Monogr. Eval. Carcinog. Risks Hum. 2004, 84, 1–477. WHO (World Health Organization). Arsenic in Drinking-water: Background document for development of WHO Guidelines for Drinking-water Quality; WHO Press, World Health Organization: Geneva, Switzerland, 2011 Wu, M.M.; Kuo, T.L.; Hwang, Y.H.; Chen, C.J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 1989, 130, 1123–1132. Tondel, M.; Rahman, M.; Magnuson, A.; Chowdhury, I.A.; Faruquee, M.H.; Ahmad, S.A. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ. Health Perspect. 1999, 107, 727–729 Thomas D. J., and Rosen B. P. (2013) Arsenic methyltransferases, in Encyclopedia of Metalloproteins (Kretsinger R. H., Uversky V. N., and Permyakov E. A., Eds.) pp 138−143, Springer New York, New York. Zhu Y. G.; Yoshinaga M.; Zhao F. J.; Rosen B. P. (2014) Earth abides arsenic biotransformations. Annu. Rev. Earth Planet. Sci. 42, 443–467. 10.1146/annurev-earth-060313-054942. Tseng, C.H. Arsenic methylation, urinary arsenic metabolites, and human diseases: Current perspective. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 2007, 25, 1–22. Antonelli R.; Shao K.; Thomas D. J.; Sams R. 2nd; Cowden J. (2014) AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility. Environ. Res. 132, 156–167. 10.1016/j.envres.2014.03.012 Vahter M. (2002) Mechanisms of arsenic biotransformation. Toxicology 181-182, 211–217. 10.1016/S0300-483X(02)00285-8. Valenzuela O. L.; Drobna Z.; Hernandez-Castellanos E.; Sanchez-Pena L. C.; Garcia-Vargas G. G.; Borja-Aburto V. H.; Styblo M.; Del Razo L. M. (2009) Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol. Appl. Pharmacol. 239, 200–207. 10.1016/j.taap.2009.06.007 De Chaudhuri, S.; Ghosh, P.; Sarma, N.; Majumdar, P.; Sau, T.J.; Basu, S.; Roychoudhury, S.; Ray, K.; Giri, A.K. Genetic variants associated with arsenic susceptibility: Study of purine nucleoside phosphorylase, arsenic (+ 3) methyltransferase, and glutathione S-transferase omega genes. Environ. Health Perspect. 2008 Naranmandura H, Chen X, Tanaka M, Wang WW, Rehman K, Xu S, et al. Release of apoptotic cytochrome C from mitochondria by dimethylarsinous acid occurs through interaction with voltage-dependent anion channel in vitro. Toxicol Sci. 2012; 128: 137–146. ( https://doi.org/10.1093/toxsci/kfs154 ) Dheeman D. S.; Packianathan C.; Pillai J. K.; Rosen B. P. (2014) Pathway of human AS3MT arsenic methylation. Chem. Res. Toxicol. 27, 1979–1989. 10.1021/tx500313k Chen J.; Sun S.; Li C. Z.; Zhu Y. G.; Rosen B. P. (2014) Biosensor for organoarsenic herbicides and growth promoters. Environ. Sci. Technol. 48, 1141–1147. 10.1021/es4038319 Marapakala K.; Qin J.; Rosen B. P. (2012) Identification of catalytic residues in the As(III) S-adenosylmethionine methyltransferase. Biochemistry 51, 944–951. 10.1021/bi201500c. Wood, T. C., Salavagionne, O. E., Mukherjee, B., Wang, L., Klumpp, A. F., Thomae, B. A., Eckloff, B. W., Schaid, D. J., Wieben, E. D., and Weinshilboum, R. M. (2006) Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. J. Biol. Chem. 281, 7364−7373. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular cloning, a laboratory manual, Cold Spring Harbor Laboratory, New York Cullen, W.R.; Reimer, K.J. Arsenic speciation in the environment. Chem. Rev. 1989, 89, 713–764. Petrick, J.S.; Ayala-Fierro, F.; Cullen, W.R.; Carter, D.E.; Vasken Aposhian, H. Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163, 203–207 Hayakawa, T.; Kobayashi, Y.; Cui, X.; Hirano, S. A new metabolic pathway of arsenite: Arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 2005, 79, 183–191. Naranmandura, H.; Suzuki, N.; Suzuki, K.T. Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 2006, 19, 1010–1018. Wood, T.C.; Salavagionne, O.E.; Mukherjee, B.; Wang, L.W.; Klumpp, A.F.; Thomae, B.A.; Eckloff, B.W.; Schaid, D.J.; Wieben, E.D.; Weinshilboum, R.M. Human arsenic methyltransferase (AS3MT) pharmacogenetics—Gene resequencing and functional genomics studies. J. Bio. Chem. 2006, 281, 7364–7373 NCBI Reference Assembly; National Center for Biotechnology Information: Bethesda, MD, USA, 2010. Available online: http://www.ncbi.nlm.nih.gov/projects/SNP/ (accessed on 10 March 2011). Dong H.; Xu W.; Pillai J. K.; Packianathan C.; Rosen B. P. (2015) High-throughput screening-compatible assays of As(III) S-adenosylmethionine methyltransferase activity. Anal. Biochem. 480, 67–73. 10.1016/j.ab.2015.04.011 Gill S. C.; von Hippel P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319–326. 10.1016/0003-2697(89)90602-7 Ajees A. A.; Marapakala K.; Packianathan C.; Sankaran B.; Rosen B. P. (2012) Structure of an As(III) S-adenosylmethionine methyltransferase: insights into the mechanism of arsenic biotransformation. Biochemistry 51, 5476–5485. 10.1021/bi3004632. Tseng, C.H. A review on environmental factors regulating arsenic methylation in humans. Toxicol. Appl. Pharm. 2009, 235, 338–350 González-Martínez, F.; Sánchez-Rodas, D.; Cáceres, D.; Martínez, M.; Quiñones, L.; Johnson-Restrepo, B. Arsenic exposure, profiles of urinary arsenic species, and polymorphism effects of glutathione-s-transferase and metallothioneins. Chemosphere 2018, 212, 927–936 Marchiset, N.; Savanovitch, C.; Sauvant, P. What is the best biomarker to assess arsenic exposure via drinking water? Environ. Int. 2012, 39. Meza, M.M.; Kopplin, M.J.; Burgess, J.L.; Gandolfi, A.J. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico. Environ. Res. 2004, 96, 119–126. Hernández, A.; Xamena, N.; Sekaran, C.; Tokunaga, H.; Sampayo-Reyes, A.; Quinteros, D.; Creus, A.; Marcos, R. High arsenic metabolic efficiency in AS3MT287Thr allele carriers. Pharm. Genom. 2008, 18, 349–355. Lesseur, C.; Diamond, D.G.; Andrew, A.S.; Ekstrom, R.M.; Li, Z.; Kelsey, K.T.; Marsit, C.J.; Karagas, M.R. A case-control study of polymorphisms in xenobiotic and arsenic metabolism Genes and arsenic-related bladder cancer in New Hampshire. Toxicol. Lett. 2012, 210, 100–106. Huang J. H.; Scherr F.; Matzner E. (2007) Demethylation of dimethylarsinic acid and arsenobetaine in different organic soils. Water, Air, Soil Pollut. 182, 31–41. 10.1007/s11270-006-9318-4. Huang Y. L.; Hsueh Y. M.; Huang Y. K.; Yip P. K.; Yang M. H.; Chen C. J. (2009) Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Sci. Total Environ. 407, 2608–2614. 10.1016/j.scitotenv.2008.12.061 Chen G. Q.; Zhou L.; Styblo M.; Walton F.; Jing Y.; Weinberg R.; Chen Z.; Waxman S. (2003) Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukaemia and lymphoma cells. Cancer Res. 63, 1853–1859. Abernathy, C. O., Calderon, R. L., and Chappell, W. (1997) Arsenic: Exposure and Health Effects, Chapman & Hall, London Sanz, M. A., Fenaux, P., Lo Coco, F., and European APL Group of Experts (2005) Haematologica 90, 1231–1235 Wang, L., Sullivan, W., Toft, D., and Weinshilboum, R. (2003) Pharmacogenetics 13, 555–564 Thomae, B. A., Rifki, O. F., Theobald, M. A., Eckloff, B. W., Wieben, E. D., and Weinshilboum, R. M. (2003) J. Neurochem. 87, 809–819 Shield, A. J., Thomae, B. A., Eckloff, B. W., Wieben, E. D., and Weinshilboum, R. M. (2004) Mol. Psychiatr. 9, 151–160 . Agusa T.; Fujihara J.; Takeshita H.; Iwata H. (2011) Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int. J. Mol. Sci. 12, 2351–2382. 10.3390/ijms12042351. Dong H.; Madegowda M.; Nefzi A.; Houghten R. A.; Giulianotti M. A.; Rosen B. P. (2015) Identification of small molecule inhibitors of human As(III) S-adenosylmethionine methyltransferase (AS3MT). Chem. Res. Toxicol. 28, 2419–2425. 10.1021/acs.chemrestox.5b00432. Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-1320965","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":123257618,"identity":"de068021-bbf2-4fcb-b22c-9bbfbd06261b","order_by":0,"name":"Pratik V. Malvade","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA+UlEQVRIiWNgGAWjYLCChAMMDHxAWoKhAkgyMzcQ0sDYANLCBtZyBqSFkQgtDDAtjG1QAXzAXPrw8wcPzmyTZ5NIfnjj47zaaP52oJYfFdtwarHsSzNsSLhx27BNIs3Ycua247kzDjM2MPacuY1Ti8EZBqCWD7cZ23gOmEnzbjuW2wDUwszYhk8L+0eQFvs2nuPfpP/OOZY7n7AWHrDDEtvYe8ykGRtqcjcQ0mLZw1M4I+HM7WSglmLLnmMHcjcCtRzE5xdzHvYNH38cu23bz8y+8caPmrrceecPH3zwowKPw9D4h8HkAZzqsWipw6d4FIyCUTAKRigAAFLdYpwuZOgxAAAAAElFTkSuQmCC","orcid":"","institution":"Pravara Rural College Of Pharmacy","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Pratik","middleName":"V.","lastName":"Malvade","suffix":""},{"id":123257619,"identity":"240ccf95-fbf8-4fbe-8932-e76519d5eeb8","order_by":1,"name":"Mayur S. Bhosale","email":"","orcid":"","institution":"Pravara Rural College Of Pharmacy","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Mayur","middleName":"S.","lastName":"Bhosale","suffix":""},{"id":123257620,"identity":"c089c852-3d50-4f6b-8cfd-6cb62b7854bf","order_by":2,"name":"Sayli R. Chavan","email":"","orcid":"","institution":"Pravara Rural College Of Pharmacy","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Sayli","middleName":"R.","lastName":"Chavan","suffix":""},{"id":123257622,"identity":"e583a12e-7f6c-4e7c-9966-8034d8b2c80d","order_by":3,"name":"Dhanashri Bhagat","email":"","orcid":"","institution":"Pravara Rural College Of Pharmacy","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Dhanashri","middleName":"","lastName":"Bhagat","suffix":""}],"badges":[],"createdAt":"2022-02-02 13:14:07","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-1320965/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-1320965/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":24307717,"identity":"ce39bcb2-540d-434b-bc4f-3dff4964e375","added_by":"auto","created_at":"2022-07-25 19:01:23","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":81970,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003e(a). Oxidative Methylation of Arsenic\u003c/strong\u003e\u003c/p\u003e\u003cp\u003e\u003cstrong\u003e\u003cspan class=\"ql-cursor\"\u003e\u003c/span\u003e(b). Oxidative Methylation of Arsenic\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"ScreenShot20220725at1.38.46PM.png","url":"https://assets-eu.researchsquare.com/files/rs-1320965/v1/e37361d0259ce93dc30a852e.png"},{"id":24307719,"identity":"e572e8f6-dffc-4edb-803d-51e9de2797fb","added_by":"auto","created_at":"2022-07-25 19:01:23","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":112348,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eAssays of Arsenic Methylation\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"ScreenShot20220725at1.38.52PM.png","url":"https://assets-eu.researchsquare.com/files/rs-1320965/v1/a8c2d26aa03a415b8c7a4916.png"},{"id":24308166,"identity":"de8120df-9116-4185-91b5-9ac6e4e4da34","added_by":"auto","created_at":"2022-07-25 19:06:23","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":185935,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eHomology structural model of human AS3MT\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"ScreenShot20220725at1.38.58PM.png","url":"https://assets-eu.researchsquare.com/files/rs-1320965/v1/a605bdb4de6d317a48183f27.png"},{"id":24307720,"identity":"b8ebe907-3aa9-4332-b0c7-ca387c5f9c93","added_by":"auto","created_at":"2022-07-25 19:01:23","extension":"png","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":135583,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eGenetic polymorphisms in AS3MT are found at the following locations. Exons are represented by dark blue rectangles. The placements of the chromosomes are also given. Arrows indicate genetic polymorphisms.\u003c/strong\u003e\u003c/p\u003e","description":"","filename":"ScreenShot20220725at1.39.13PM.png","url":"https://assets-eu.researchsquare.com/files/rs-1320965/v1/4f2fa7a5e39d88ab54293859.png"},{"id":24308167,"identity":"05172b02-3589-46c6-ace2-c5e6e16e01f4","added_by":"auto","created_at":"2022-07-25 19:06:26","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":743041,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-1320965/v1/f2669a82-94b4-40bf-b110-3723384f4223.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"\u003cp\u003eMetabolism of Arsenic in Human by AS3MT Gene\u003c/p\u003e","fulltext":[{"header":"Introduction","content":"\u003cp\u003eAs humans get evaluated they get custom-made to the surrounding environment. The adaption happens i.e. mutation \u003csup\u003e[1,2]\u003c/sup\u003e.\u003csup\u003e\u0026nbsp;\u003c/sup\u003eMutation allows organisms to metabolize toxic things \u003csup\u003e[3]\u003c/sup\u003e. The peoples can still metabolise low level. Scientists found that due to more consumption of arsenic water, the body has developed a genetic ability to metabolize arsenic. Scientists found that peoples of Andes can do metabolism arsenic.\u0026nbsp;\u003csup\u003e[4]\u003c/sup\u003e.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eArsenic can comeinbody from drinking water sources such as Inorganic Arsenic (iAs) in As\u003csup\u003eIII\u0026nbsp;\u003c/sup\u003eor As\u003csup\u003eV\u0026nbsp;\u003c/sup\u003ei.e. arsenite or arsenate \u003csup\u003e[5,6]\u003c/sup\u003e. The As\u003csup\u003eIII\u0026nbsp;\u003c/sup\u003e(Arsenite) species are AsO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e-\u003c/sup\u003e, HAsO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e2\u0026minus;\u003c/sup\u003e, H\u003csub\u003e2\u003c/sub\u003eAsO\u003csub\u003e3\u003c/sub\u003e\u003csup\u003e\u0026minus;\u003c/sup\u003e and H\u003csub\u003e3\u003c/sub\u003eAsO\u003csub\u003e3\u003c/sub\u003e,\u003csub\u003e\u0026nbsp;\u003c/sub\u003ewhile As\u003csup\u003eV\u0026nbsp;\u003c/sup\u003e(Arsenate) species are:\u0026nbsp;AsO\u003csub\u003e4\u003c/sub\u003e\u003csup\u003eIII\u0026minus;\u003c/sup\u003e, HAsO\u003csub\u003e4\u003c/sub\u003e\u003csup\u003e2\u0026minus;\u003c/sup\u003e, H\u003csub\u003e2\u003c/sub\u003eAsO\u003csub\u003e4\u003c/sub\u003e\u003csup\u003e\u0026minus;\u003c/sup\u003e and H\u003csub\u003e3\u003c/sub\u003eAsO\u003csub\u003e4\u003c/sub\u003e. Group I type compounds i.e. inorganic arsenic \u003csup\u003e[7]\u003c/sup\u003e. The safe levelof arsenic indrinking water is 10 \u0026micro;g/L as per WHO \u003csup\u003e[8]\u003c/sup\u003e. High arsenic exposure can show effects like skin pigmentation, hyperkeratosis, and cancer of bladder, liver, and kidney which may cause deaths \u003csup\u003e[9, 10]\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003eThe arsenic metabolises by dual pathways, which are oxidative methylation and reductive methylation. During metabolism arsenic transformed to Methylarsenite (MAs\u003csup\u003eIII\u003c/sup\u003e), Dimenthylarsenite (DMAs\u003csup\u003eIII\u003c/sup\u003e), and sometimesmaybee to Trimethylarsine (TMAs\u003csup\u003eIII\u003c/sup\u003e) by the enzyme As\u003csup\u003eIII\u003c/sup\u003e S-adenosylmethionine methyltransferase (SAM) \u003csup\u003e[11,12]\u003c/sup\u003e. \u0026nbsp;In the gastrointestinal tract the Methylarsenite (MAs\u003csup\u003eIII\u003c/sup\u003e), Dimenthylarsenite (DMAs\u003csup\u003eIII\u003c/sup\u003e) are get methylated to form Monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). MMA and DMA are less toxic than both MAs\u003csup\u003eIII\u0026nbsp;\u003c/sup\u003eand DMAs\u003csup\u003eIII\u0026nbsp;\u003c/sup\u003eso they are readily excreted through urine, where they get oxidized abiotically to MAs\u003csup\u003eV\u0026nbsp;\u003c/sup\u003eand DMAs\u003csup\u003eV\u003c/sup\u003e \u003csup\u003e[13]\u003c/sup\u003e. When the MAs\u003csup\u003eV\u0026nbsp;\u003c/sup\u003eand DMAs\u003csup\u003eV\u0026nbsp;\u003c/sup\u003elevels increase in the urine is an indication of Arsenic related diseases \u003csup\u003e[14]\u003c/sup\u003e. The distribution of arsenic metabolites in urine is 10\u0026ndash;30% iAs, 0-11% MAs and 26-30% DMAs, but this distribution can vary from individual to individual \u003csup\u003e[15]\u003c/sup\u003e. Single Nucleotide Polymorphisms in the hAS3MT gene are linked. Most SNPs have little effect on health, however the M287T SNP in hAS3MT can cause cancer and skin issues \u003csup\u003e[16,17]\u003c/sup\u003e. When methylation of inorganic arsenic occurs it produces toxic compound than previous \u003csup\u003e[18]\u003c/sup\u003e. For example, one protective The AS3MT haplotype is prevalent in indigenous tribes in Argentina they consumed arsenic toxic water for long period. The concentration of arsenic in water is 0.8 mg/L and little urine excretion of MAs (7.5 %) and a greater percentage of DMAs (78 %).\u003c/p\u003e\n\u003cp\u003eIn this study, we reviewed the human genetic related to AS3MT to find out ability of enzymes to metabolise arsenic and the effect of amino acid substitution on it. Methylation of arsenic helps to prevent death and sever conditions. For this study, we synthesized the hAS3MT gene by bacterial synthesis, which helps us to get pure AS3MT for further study. Then we compare the properties of enzymes in between hAS3MT and AS3MT by using As\u003csup\u003eIII\u0026nbsp;\u003c/sup\u003eionized molecule, which allows us to relate the structural and enzymatic property of both. In this, we show that AS3MT is essential for arsenic methylation capacity and present evidence that HGTs (Horizontal Gene Transformation) from prokaryotes to eukaryotes underlie adaptations to arsenic which is also known as mutation. In this study we discussed about how the animals get evaluated from last centuries \u003csup\u003e[19]\u003c/sup\u003e.\u003c/p\u003e"},{"header":"Materials And Methods","content":"\u003cp\u003eWe declare that, all methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by a Pravara Rural College Of Pharmacy, Pravaranagar. All experiments were performed in accordance with relevant guidelines and regulations.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eReagents\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eTris-(2-carboxyethyl)-phosphine (0.5 M, pH 7) was prepared. MAs\u003csup\u003eV\u003c/sup\u003e was reduced to trivalent MAs\u003csup\u003eIII\u003c/sup\u003e using Na\u003csub\u003e2\u003c/sub\u003eS\u003csub\u003e2\u003c/sub\u003eO\u003csub\u003e3\u003c/sub\u003e, Na\u003csub\u003e2\u003c/sub\u003eS\u003csub\u003e2\u003c/sub\u003eO\u003csub\u003e5,\u003c/sub\u003e and H\u003csub\u003e2\u003c/sub\u003eSO\u003csub\u003e4\u003c/sub\u003e and adjusted to pH 6.5 with NaOH \u003csup\u003e[20]\u003c/sup\u003e. High-Performance Liquid Chromatography (HPLC) coupled to inductively coupled mass spectroscopy validated the identities of the reduction products (ICP-MS). The methylation substrates were the Glutathione (GSH) conjugates As(GS) and MAs(GS), which were made by incubating 1 mM AsIII or MAsV with a four-fold molar excess of GSH in degassed buffers under argon for 5 hours at 23 \u0026deg;C. \u003csup\u003e[21]\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eStrains \u0026amp; Growth Conditions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eFor plasmid E. coli was used by (Dheeman D. S.; Packianathan C.). Bacterial growth was monitored by measuring the optical density at 600 nm (A\u003csub\u003e600nm\u003c/sub\u003e) \u003csup\u003e[19]\u003c/sup\u003e.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHuman AS3MT Gene Cloning of hAS3MT cDNA\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eChemically synthesized hAS3MT gene matching to the sequence of the cDNA clone, which lacks the final nine residues of the hAS3MT sequence, with codon optimization for expression in E. coli and sub-cloned into the EcoRV site of pUC57-Kan-hAS3MT. The synthetic hAS3MT gene was cloned into expression vector pMAL-c2x as an EcoRI/SalI digest from pUC57-Kan-hAS3MT, resulting in a fusion with the maltose-binding protein gene at the 5\u0026prime; end and eight histidine residues at the 3\u0026prime; end of the genomic sequence. The forward primer 5\u0026prime;-CCAGCCATGGCTGCACTTCGTGACGCTGAGA-3\u0026prime; (NcoI site highlighted) and reverse primer 5\u0026prime;-CCTAGTCGACTCCAGCAGCATCAGGGACACATC-3\u0026prime; were used to amplify the 1.1 kb fragment using PCR (SalI site underlined) \u003csup\u003e[19,22]\u003c/sup\u003e.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConstructing Mutation\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eSite-directed mutagenesis used to create mutations in the AS3MT gene. The conserved Cys32, Cys61, Cys156, and Cys206 residues were altered to serine codons, resulting in seven single-cysteine mutants of the synthetic hAS3MT. Commercial DNA sequencing verified each hAS3MT mutation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eExpression and Purification of Protein\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eBy using the Ni-NTA chromatography Wild-type AS3MT (87 837 Da) and variant enzymes are purified by using \u003cem\u003eE. coli\u003c/em\u003e \u003csup\u003e[19]\u003c/sup\u003e. Cells carrying the plasmid pET41a-hAS3MT were grown at 37 \u0026deg;C in 1 L of Luria Broth medium with 10 gm of tryptone, 5 gm of yeast extract, and 10 gm of NaCl per litre containing 50 g/mL Kanamycin for 3 hours before induction with 0.3 mM isopropyl -D-1-thiogalactopyranoside (IPTG) After centrifuging the induced culture at 5000 rpm for 15 minutes at 4 \u0026deg;C, it was suspended in 20 mL of buffer A containing 50 mM NaH2PO4 (pH 8.0), 1 mM TCEP, and 0.3 M NaCl, to which 10 mM imidazole was added. The cells were lysed in the presence of Di-isopropyl fluorophosphate using a press before being centrifuged at 35000 rpm for 1 hour. Then, apply the aforementioned solution (0.7 mL/min) to a Ni-NTA agarose column that has already been loaded with 5 column volumes of buffer. hAS3MT was then eluted (0.7 mL/min) with 8 column buffer containing 0.25 M Imidazole after being column washed (1 mL/min) with 10 of buffer containing 20 mM Imidazole. The Imidazole is then removed. As previously disclosed, natural hAS3MT was purified. Purify thioredoxin (Trx) and thioredoxin reductase (TR) from E. coli BL21(DE3) bearing either pET14b-trxA or pET14b-taxi using Ni-NTA chromatography as stated above. Before use, all buffers were degassed (aliquoted) by bubbling with argon for 30 minutes \u003csup\u003e[19]\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cu\u003eMETABOLISM OF ARSENIC (AS3MT)\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThere are two pathways by which the human body metabolize the arsenic compound i.e. Methylation by Oxidation and Reduction type of reaction\u003c/p\u003e\n\u003cp\u003eThe activity of AS3MTs was checked at 37 \u0026deg;C in a buffer of 50 mM NaH\u003csub\u003e2\u003c/sub\u003ePO\u003csub\u003e4\u003c/sub\u003e pH 8 \u0026amp; 0.3 M NaCl. The chemicals in the assay are 5 mM GSH, 1 mM SAM, 10 \u0026mu;M Trx, 3 \u0026mu;M TR, and 0.3 mM NADPH, and the reactions were terminated by adding 10% (v/v) H\u003csub\u003e2\u003c/sub\u003eO\u003csub\u003e2\u003c/sub\u003e to oxidize all arsenic species. Centrifugation using a 3 kDa cut-off Amicon ultra-filter was used to remove denatured protein. Then analysed by using HPLC.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eOxidative Methylation\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis process is also called as bioactive process. This pathway is given by Cullen and Reimer. By the combination of Oxidative methylation, arsenate (As\u003csup\u003eV\u003c/sup\u003e) is changed to Dimethylarsinous acid (DMA\u003csup\u003eIII\u003c/sup\u003e). Then Arsenate (As\u003csup\u003eV\u003c/sup\u003e) gets converted into Arsenite (As\u003csup\u003eIII\u003c/sup\u003e) following to Monomethylarsonic acid (MMA\u003csup\u003eV\u003c/sup\u003e) then it gets converted into Mono-methylarsonous acid (MMA III). Then MMA III\u003csup\u003e\u0026nbsp;\u003c/sup\u003econverts into Dimethylarsinic acid (DMA\u003csup\u003eV\u003c/sup\u003e) and finally it forms Dimethylarsinous acid (DMA\u003csup\u003eIII\u003c/sup\u003e). We can\u0026rsquo;t explain the complete metabolism process because of the detection of DMV\u003csup\u003eV\u0026nbsp;\u003c/sup\u003earsenic which occurs in a major amount in human urine. Because the toxicity of MMAV and DMAV is substantially lower than that of iAs, methylation is thought to be a detoxification step for iAs. According to several recent investigations, MMAIII or DMA III are more cytotoxic and genotoxic than iAs. \u003csup\u003e[24,25]\u003c/sup\u003e. We noticed that if we cannot add H\u003csub\u003e2\u003c/sub\u003eO\u003csub\u003e2\u0026nbsp;\u003c/sub\u003eit allow us to determine trivalent arsenicals.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eReductive Methylation\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis pathway of arsenic was proposed by Hayakawa \u003cem\u003eet. al\u0026nbsp;\u003c/em\u003e\u003csup\u003e[26]\u003c/sup\u003e\u003cem\u003e.\u0026nbsp;\u003c/em\u003e In this pathway, trivalent arsenicals are conjugated with glutathione (GSH) and then they get methylated. In the first step, As\u003csup\u003eIII\u003c/sup\u003e changes to As\u003csup\u003eIII\u003c/sup\u003eGS3 then MMA\u003csup\u003e+\u003c/sup\u003e3GS2 is formed then later it gets reduced to Dimethylarsenoglutathione (DMA\u003csup\u003eIII\u003c/sup\u003eGS) [As in Figure. 1(b)]. Then correspondingly the MMA\u003csup\u003e+\u003c/sup\u003e3GS2 and DMA\u003csup\u003eIII\u003c/sup\u003eGS are get oxidized to MMA\u003csup\u003eV\u003c/sup\u003e and DMA\u003csup\u003eV\u003c/sup\u003e. We investigated the renal metabolites and hepatic metabolites after giving the arsenic intravenously to the mice (0.5 mg/kg body weight), then we observed that when a trivalent species (As\u003csup\u003eIII\u003c/sup\u003e) of arsenic binds to a thiol group (R-SH) present in proteins. Then the protein-arsenical complex detaches from a parent protein and forms conjugation with Glutathione (GSH) to form As\u003csup\u003eIII\u003c/sup\u003e(GS)\u003csub\u003e3\u003c/sub\u003e or MMA\u003csup\u003eIII\u003c/sup\u003e(GS)\u003csub\u003e2\u003c/sub\u003e or DMA\u003csup\u003eIII\u003c/sup\u003e(GS). Hence it is found that during reductive methylation MMA\u003csup\u003eV\u003c/sup\u003e and DMA\u003csup\u003eV\u003c/sup\u003e are the end products. But in this pathway, DMA\u003csup\u003eV\u003c/sup\u003e is in the major amount present in urine called as detoxification \u003csup\u003e[27]\u003c/sup\u003e.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAt the point when iAs is methylated through Oxidative and Reductive Methylation, the AS3MT quality assumes a basic part. AS3MT is an S-adenosyl-L-methionine-subordinate compound that can methylate trivalent arsenicals \u003csup\u003e[28]\u003c/sup\u003e. The human AS3MT gene is 32 kb long and has 11 exons. A variety of genetic variations SNP. A VNTR is a spot in DNA where a short nucleotide sequence is organized \u003csup\u003e[28]\u003c/sup\u003e. \u0026nbsp;When AS3MT methylates inorganic arsenic, it can cause oxidative DNA damage and enhance their carcinogenicity.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cu\u003eAssays of Arsenic Methylation\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eTo assay measurement of conversion of SAM to S-adenosylhomocysteine (SAH) EPI generous Methyltransferase Assay kit is used where the time-resolved F\u0026ouml;rster resonance energy transfer (TR-FRET) is used [\u003csup\u003e30]\u003c/sup\u003e. The test was completed utilizing a 384-well microtiter plate in a cushion comprising of 50 mM NaH2PO4 (pH 8.0), containing 0.3 M NaCl, 1 \u0026mu;M cleaned hAS3MT, 0.5 mM GSH, 1 \u0026mu;M Trx, 0.3 \u0026mu;M TR and 0.03 mM NADPH and 10 \u0026mu;M of As(GS) or MAs(GS). Then we added the SAM at 10 \u0026mu;M. The emission was 665:620 nm for determine Homogeneous Time-Resolved Fluorescence (HTRF). The concentration calculated as given in Fig. 2. \u003csup\u003e[30]\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003eFor measurement, (HPLC) and for arsenic concentration Inductively Coupled Plasma Mass Spectrometry (ICP-MS) was used \u003csup\u003e[19]\u003c/sup\u003e. Then added the SAM to at 37\u0026deg;C. To recuperate the entirety of the arsenic, the responses were ended by the expansion of H2O2 at 10% (v/v) last fixation, which additionally oxidizes all arsenicals, so the items will be named MAs and DMAs. Speciation of arsenic in the still up in the air by HPLC with a C18 300A opposite stage section with the arsenic focus estimated by ICP-MS utilizing an ELAN 9000 ICP-MS. AsIII, MAIII, DMAV, MAV, and AsV were utilized at 1 \u0026mu;M as principles.\u003c/p\u003e\n\u003cp\u003eE. coli cells expressing the genotype and mutants of the hAS3MT gene. Hence, we carried both methylation processes on them. The cells were grown for 12 hours at 37 \u0026deg;C in a 2 mL liquid broth medium of 0.3 mM Isopropyl-D-1-thiogalactopyranoside (IPTG), 100 g/mL kanamycin, and 10 M of AsIII or 2 M MAIII or both was used. The cells were extracted, washed, and suspended in ST-1 media with 2 M MAIII before being cultured at 37 \u0026deg;C for 3 hours. Arsenicals were speciated by HPLC using a C18 reverse phase column, and the quantity of arsenic was calculated by Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) (ICP-MS).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cu\u003eHAS3MT STRUCTURE HOMOLOGY MODEL WITH POLYMORPHIC RESIDUES\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eUsing a fully automated protein structure homology modelling system, a homology model of hAS3MT was generated from residues on the structure of PhAsIII, which is confined to CmArsM. We utilize the PATCHDOCK server to find SAM\u0026apos;s position in the model. The AsIII bound structure of CmArsM [32] was overlaid on the found hAS3MT model using SAM. We used a visual technique to get the arsenic atom in the AsIII binding site of hAS3MT. As seen in Fig. 3. The human AS3MT model structure is depicted in a cartoon diagram with a tan colour scheme.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eThe Relationship between Arsenic Methylation and Genotypes in Human AS3MT\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIn this study, we employ SNP, which stands for polymorphism identification number related to the consensus sequence site (AY817668), with the first base of the consensus number 1 and dbSNP rs# cluster id \u003csup\u003e[29]\u003c/sup\u003e. Figure 4 depicts the chromosomal positions of genetic polymorphisms in AS3MT.\u003c/p\u003e\n\u003cp\u003eOut of all SNPs, three of them has non-synonymous exon region, which is Arg173Trp, Met287Thr, and Thr306Ile. When these AS3MT-expressing cells are treated with 12.5 nM AsIII, the Met287. During our study, we discovered that repeated sequences of 5\u0026apos;-UTR VNTR influences the transcriptional expression of gene. According to the findings of this study, polymorphisms in AS3MT lead to individual variability in AS3MT expression and function, as well as variance in the risk of arsenic-dependent carcinogenesis.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cu\u003eANIMAL CASE STUDY\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis study was conducted. The selected animals (mice\u0026rsquo;s) are treated with arsenic containing water in different concentrations.\u003csup\u003e[34]\u0026nbsp;\u003c/sup\u003e\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCollection of different samples\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cu\u003eGroundwater sample collection\u003c/u\u003e\u003c/p\u003e\n\u003cp\u003eWe collected the water from 15 random groundwater wells in the polythene bottle which is previously treated with 25% HNO\u003csub\u003e3\u0026nbsp;\u003c/sub\u003efor 3 hours. Then the bottles are washed with water. After sample were kept under refrigerated at the laboratory.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cu\u003eBlood sample collection\u003c/u\u003e\u003c/p\u003e\n\u003cp\u003eBlood samples from subjects were collected by venous puncture using lead-free vacutainer tubes containing EDTA as an anticoagulant. The blood was collected from all subjects and transferred to laboratory for study. DNA was extracted through the HP-PCR (High Pure-Polymerase Chain Reaction).\u003c/p\u003e\n\u003cp\u003e\u003cu\u003eCollection of a urine sample\u003c/u\u003e\u003c/p\u003e\n\u003cp\u003eApproximately 15 ml of urine sample is collected bottle and the bottle is cleaned as mentioned in Groundwater is also collected. The sample was freeze to prevent oxidation. Then sample was filtered to remove unwanted waste.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRisk Assessment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe following calculation was used to assess human exposure to arsenic in groundwater using the Lifetime Average Daily Dose (LADD), which is the amount of daily arsenic exposed from one or more sources and is given in g of arsenic per kilogramme body weight per day (g/kg/day):\u003c/p\u003e\n\u003cp\u003e\u003cimg src=\"data:image/png;base64,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\"\u003e\u003c/p\u003e\n\u003cp\u003eWhere,\u003c/p\u003e\n\u003cp\u003eC\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; - Arsenic concentration in water (\u0026micro;g/L),\u003c/p\u003e\n\u003cp\u003eIR\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp; - The water intake rate per day (L/day),\u003c/p\u003e\n\u003cp\u003eED\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;- Exposure duration (years),\u003c/p\u003e\n\u003cp\u003eEF \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- The exposure frequency (days/year),\u003c/p\u003e\n\u003cp\u003eKg\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;- The body weight/Kg,\u003c/p\u003e\n\u003cp\u003eAT \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- The average time (day)\u003c/p\u003e\n\u003cp\u003eBy the LADD value we determined the Hazard Quotient (HQ) by the following equation;\u003c/p\u003e\n\u003cp\u003e\u003cimg src=\"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAGYAAAAyCAYAAACuwK6DAAABRWlDQ1BJQ0MgUHJvZmlsZQAAKJFjYGASSSwoyGFhYGDIzSspCnJ3UoiIjFJgf8bAziDJwM2gySCWmFxc4BgQ4ANUwgCjUcG3awyMIPqyLsisrdMF087PrajTVWk6khvo2YWpHgVwpaQWJwPpP0CcmlxQVMLAwJgCZCuXlxSA2B1AtkgR0FFA9hwQOx3C3gBiJ0HYR8BqQoKcgewbQLZAckYi0AzGF0C2ThKSeDoSG2ovCHC7uPr4KIQamRiaEnAtGaAktaIERDvnF1QWZaZnlCg4AkMpVcEzL1lPR8HIwMiIgQEU5hDVn2+Aw5JRjAMhlv+RgcH8HJBxDCGWMJmBYds7oLe/I8TUghgYBF0YGPYWFCQWJcIdwPiNpTjN2AjC5t7OwMA67f//z+EMDOyaDAx/r////3v7//9/lzEwMN9iYDjwDQCQnGBlB8mXEAAAAFZlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA5KGAAcAAAASAAAARKACAAQAAAABAAAAZqADAAQAAAABAAAAMgAAAABBU0NJSQAAAFNjcmVlbnNob3QgOy5TAAAB1WlUWHRYTUw6Y29tLmFkb2JlLnhtcAAAAAAAPHg6eG1wbWV0YSB4bWxuczp4PSJhZG9iZTpuczptZXRhLyIgeDp4bXB0az0iWE1QIENvcmUgNi4wLjAiPgogICA8cmRmOlJERiB4bWxuczpyZGY9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkvMDIvMjItcmRmLXN5bnRheC1ucyMiPgogICAgICA8cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0iIgogICAgICAgICAgICB4bWxuczpleGlmPSJodHRwOi8vbnMuYWRvYmUuY29tL2V4aWYvMS4wLyI+CiAgICAgICAgIDxleGlmOlBpeGVsWURpbWVuc2lvbj41MDwvZXhpZjpQaXhlbFlEaW1lbnNpb24+CiAgICAgICAgIDxleGlmOlBpeGVsWERpbWVuc2lvbj4xMDI8L2V4aWY6UGl4ZWxYRGltZW5zaW9uPgogICAgICAgICA8ZXhpZjpVc2VyQ29tbWVudD5TY3JlZW5zaG90PC9leGlmOlVzZXJDb21tZW50PgogICAgICA8L3JkZjpEZXNjcmlwdGlvbj4KICAgPC9yZGY6UkRGPgo8L3g6eG1wbWV0YT4KsSvdPQAACY1JREFUeAHtW2eIFEsQrjvPnHPOOeccEBUjCopZFLOIWUTxl1nE/MOsiJgRMWDADEaMqJizKGLOitl+9RX20LMTds/z3u3tbcHedFfXdM9UTXdXfV0Xo5goSmGngdiwe6LoA4kGooYJ0w8hapioYcJUA2H6WNEZEzVMmGogTB8rLkyfK0GPtXv3bjpw4ID0ERMTQ/Pnz6dUqVL59nn69GmaMWMGjRgxglq2bGnJ/v79m8aOHUu4gtBP5syZqWbNmtShQwdC/yaZY4OfLl06yps3L3Xr1o0KFSpkivqXEcdEGj19+lQVK1YM8ZlasmRJSK/Hihb5WbNm2eTZIGr69OnSVr9+fSl37txZxcXFqfLly6vHjx/b5M2xp06dqsaMGaNKly6t0qdPr6ZNm2aT9auQX2NybitevLjKlSuXgmKD0cqVK1XOnDlF+RMmTHCIox1GXrhwodW2bds24TVq1Mji6QLGLlCggK6qr1+/qjp16qjY2Fi1f/9+i+9XiEjDvH//Xr5oXpL83l3aPn78KErk5U4UPWTIEMc9w4YNk7YLFy7Y2qpXr654KVMYT5Meu02bNpol1+3bt0sfQ4cOtfG9KhHplZ08eZJ+/vxJdevW9V/HuXXSpEmUO3duGj58uMi+ffvWcc+5c+coW7ZsVK1aNVtbyZIl8WHTlStXLL7X2BUrVhSZW7duWbJ+hYjc/E+cOCHv3LBhQ793p3v37tHy5ctp586dlDp1asqQIQPxF2+758ePH3T9+nWqWrUq8VJka+PZJnU4A5q8xtb9ZsyYUYv6Xu0j+Yomn8azZ88Sb84UzDCjRo2ipk2bUvPmzeXloDStQP2258+fp0+fPlHt2rU1y7o+evRIyiVKlLB4GDtNmjTUoEEDi4eCnimFCxe28b0qETljLl++TGXLlqVMmTJ5vbe403v27KEqVapQ69atRQ4G+PDhg+2e48ePS91N0Xfu3KEaNWrYxtFjY/aZhFkJMl1xs91R9tp8kiv/xo0bssn26dPH9gqbNm1SvFcI79evX6pChQqqS5cuiuMd6wdvir9o232dOnWS/p49e2bj9+rVS/iLFy+2+Hrsvn37WjwUeMlUPItUkSJFQvIScU/EeWXLli0ThS1duhTvJ/Ty5UuVNWtWdfDgQanPnTtX8bKlEHOYVKtWLZEzeUWLFpWYyOStWbNGFA1XGUbWpMfmfUuz1Js3b8RVRtyzd+9eix+sEHGG0V/41atX5d1hlBYtWihe1tS3b9/UgwcPVPbs2RXvPw7dcGQuRn348KG06RnQsWNHiUXY41Ljxo2TeARGDJxFemx2FhTvP2rz5s0ShCK4XLRokWM8P0ZEGQaxCII4Xq9lRmBWoIxf48aNRVla+WnTplXr16+3dNO7d29LFsEg4pFSpUoJjz02idzz5MmjYJDZs2er79+/W/eiYI6NjwA/oA89e/ZUgfGP7UaPSgz4jo0nykhyDfh6ZSYgZ4KBW7ZsIe2vwzXkNdv2IvBsDh06JD+U+Qskjp6DAom2TlJ6xWMmCRubIzwV1pENDMT6yYip8LGOmoR1GcsFNs2JEyeqAQMGyLLSrFkzUyxaDqKBoHsMkFE3MDBfvnwOb+XatWsqf/784hbCG9HUo0cPMaL2ijQ/evXWgG/kj2WIvRgJosxzB4a6iT0SWaLMFWf8+PH0/Plz2rBhA7HnYzVpzOrSpUsWL1rw14DvHqMBuXr16tl6OXr0qNRN/v3794khbQEO2b+3ySOiBrHPb+ObFXwAet8y+W7l7t27C7bl1hYpPF/DaEUBXcUpnqZTp05JsUmTJppFHAELotu1a1eLpwsAAUG8LGqW43rkyBFxEBwNLoz27dsL2uvSFDEsX8MAkAPqiplhLmUcgBFH0sTnEZYigBGB+HTP4umCBvAYBtEsx5WdBMIvSn804L39KMXnFKpSpUo2EUTPCNwY1LPxGWF1wBkQgBMAeRzDJjbxK4mTkRyuwXThOWNu3rxJDGdQ27ZtbR8xlrXPnz87Nn4cMOHAKZBWrFgh8v369QtsstU3btxIcB6CEWYue3+UJUsWhyi/rIOXXBmehtEbPCcg2N7t2LFjUg/k47wCzgLPKGK4Q2Tguc2bN484FqLBgwfb+gms4HRw5MiRgWxHHYZB5knEk9eU0oAcG8gmgkCRlaL4ONXGB0gHPjAjJECwl6X41E8AQ95/bLLJsfLu3TsHGp2Y7+GKlS1YsIAYRZVcKgbtCMsXaPLkyTRlyhQps4Ho8OHDUsYfuMTYvAHj4IDq1atXxKgsceoPlStXzpJLqgLywsz8MDwHZjbO7ZHzZcZd5jOuW7eO1q5dS3fv3iU4Pfv27aNWrVqJbsz+guWbmX2GVP7XVkeqDp/qKaC3L168+Nfd/3V/mMXI62KlKF521Zw5c9To0aMlbalgwYKus4EDYjl34ZNOQZs5FFDIqgGhv/jkm8X3wYNCMvHtEPJ4aSigf//+ArVjWQw8lPqbfhN6z6pVq+S5cFCmCYdaeNaZM2dqlnWF58mz3aoHFuKbbxZ4v1/dF5IJacq5CCHNFIjy6tWrZRnDuThjay6S/y/r4sWLMqCJTAAdByFeMwkoBgJpDhckkeL169dms5Q1xMRnPVYblm/Ed3CEAvMHLKFQCn5WS2gbwzTqy5cvCe3mn92PAzB2sxXnnFl9YjbjIMyc0YMGDZKYjPUnAC6QdByOBRL643wz2/EyZJBCi3sZOQm8JeR6oixlIY/+PwrixBGnioxiiGFw9MxJftaSG/gouu3JkyeBTVLX/bkdUbNzIP0mxBtNMYbhZUmUhfN3GAhfNNCKHTt2uCoeDgLOlbxI9wcHIpCAcqB/7SgEtodST5Q9hh8q7Ejnh3GGCzFMJPldOKKoXLmy41l5NljZl47GPwzdX6j5Zl79ePFTjGHOnDkjOgAijo0eEBGgJU7IcOgGsm6wkylo9mfy2SUXlD3BgGwo0yoSZHDUjZ8m/F8LK1QFZuWjXccnSAb0IvSFLBiTeDa65puZMqGWU8Qeo/PDOE/ZphdkRubIkUOxW2vjt2vXTv6Nw2uP0P2Fmm9m6zzESsQbxswPQzYmo92WapDzhVlTpkwZBSxME/7pyOuYwuwPbjacCb98M91nfK8Rb5j4KuT27dtirIEDB8b31n8qn2I2f3OD9itv3bpVmjnh3E8s0dtc0eVEHzUMB2Dwlfj/KgWBhgvNqVZJ+pTRGfNH/fgnJMD7DMfQrl27ktQoGDw6Y5LcBO4PEJ0x7npJcm7UMEluAvcH+A/q41cCSO1EOwAAAABJRU5ErkJggg==\"\u003e\u003c/p\u003e\n\u003cp\u003eWhere,\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eRfD\u003c/em\u003e is reference dose for arsenic is 10 \u0026micro;g/kg/day as given by WHO for India to avoid non-cancerous outcomes such as hyperpigmentation, keratosis, and possible vascular complications.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetermination of Groundwater Quality and Arsenic\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIt was necessary to check turbidity, pH, conductivity, temperature, dissolved oxygen, chloride, fluoride, nitrite, nitrate, magnesium, and other physiochemical parameters. In the laboratory, chloride (mg/L) and fluoride (mg/L) were measured using a Benchtop Multiparameter pH/ISE with the appropriate ion-selective electrodes.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eUrinary Arsenic Species (UAs) determination by Instrumental Analysis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eUsing HPLC-HG-AFS, the urinary arsenic species (UAS) (AsIII, AsV, MMA, and DMA) were determined (High-Performance Liquid Chromatography-Hydride Generation-Atomic Fluorescence Spectrometry). A Hamilton PRP-X100 anion-exchange column with a diameter of 250 mm aqueous buffer KH2PO4 or K2HPO4 with a pH of 5.8 is used as the mobile phase. The flow rate was 1.0 mL/min. To find out Total Urinary Arsenic, the urine sample is subjected within HNO3 and HClO4 to convert arsenic to inorganic arsenic (iAs). Finally, the HG-AFS method is employed to calculate UAs (Hydride Generation-Atomic Fluorescence Spectrometry).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eQuality Assurance for Arsenical\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eLimit of detection (LOD) and limit of quantification (LOQ) were employed to detect arsenic in water, yielding values of 0.7 g/L and 1.2 g/L, respectively. The concentration of arsenic in urine is measured. We reported 106.22 g/L of total iAs, which is the sum of the AsIII and AsV. We also used HPLC-HG-AFS to verify the recovery of arsenic species, yielding a total of 107.8 2.4 g/L, which matched to 99.5 2.1 g/L of AsV and 8.3 0.3 g/L of DMA. The following were the Urinary Arsenic Species (UAS) Limits of Detection (LOD): AsIII is 0.17 g/L, AsV is 0.38 g/L, MMA is 0.30 g/L, and DMA is 0.45 g/L.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cu\u003eSTATISTICAL ANALYSIS\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eBecause arsenic concentrations in groundwater and urinary arsenic species do not have a normal distribution. The genotype distributions of GSTP1-rs1695, GSTO2-rs156697, and As3MT-rs3740400 were measured using the Hardy-Weinberg equilibrium (HWE). Allelic frequencies were obtained by dividing the frequencies of heterozygous and homozygous alleles by the total number of allelic variants. We split the total number of individuals into two groups: those with a low daily dosage (LADD 0.3 g/kg/day) and those with a high daily dose (LADD \u0026gt; 0.3 g/kg/day). We do the comparison between low and high exposure doses. To understand the differences between low and high intake of toxics, an effect size test was performed \u003csup\u003e[37].\u003c/sup\u003e The polymorphisms and LADD were used as independent factors in the study, while urine arsenic species were used as dependent variables. The study included genetic dominant models (heterozygous + homozygous genotype) as well as possible confounders (age, BMI, smoking history, and lifestyle). With a stronger biological sense, dominant models over Potential Confounders model are explored in the research population. We used various factors to analyse the multi-collinearity of independent variables (VIF) \u003csup\u003e[38]\u003c/sup\u003e.\u0026nbsp;\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eDuring the transformation of arsenic, the conversion of inorganic arsenic to Methylarsonic acid and dimethylarsinic acid is the most important step \u003csup\u003e[42]\u003c/sup\u003e. On basis of metabolism processes of arsenic we was curious to find that is it is suitable to inhibit cancer or not \u003csup\u003e[43]\u003c/sup\u003e.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eThe main step is to give annotation of the AS3MT gene, resulting in several differences from the current \u0026ldquo;provisional\u0026rdquo; NCBI annotation. During the re-sequencing, we identified 27 polymorphisms, including three non-synonymous cSNPs and a VNTR. For allozymes, Trp\u003csup\u003e173\u003c/sup\u003e and Ile\u003csup\u003e306\u003c/sup\u003e, levels of enzyme activity and immune-reactive protein were strikingly decreased when compared with the WT allozyme. \u003csup\u003e[44,45,46]\u003c/sup\u003e.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAll of the substituted residues are on the surface of the protein except for Thr306, which is buried inside the enzyme, so a T306I substitution is disrupt the structure (figure 3). The second methylation step is reduced when M287T SNP is occur \u003csup\u003e[47]\u003c/sup\u003e. Met287 is located on the surface of AS3MT where the molecular inhibitors bind \u003csup\u003e[48]\u003c/sup\u003e. We also see that when M287T substitutes the binding site it retards the allosteric conformational change and reduces the rate of methylation of this variant. This property is observed in individuals with the M287T polymorphism epidemiological studies.\u003c/p\u003e\n\u003cp\u003eDuring the stability study in temperature, we found that the variants denature between 4 to 20 fold faster than wild-type hAS3MT. The protective AS3MT polymorphisms are located outside of the coding sequence regulatory elements.\u003c/p\u003e"},{"header":"Results","content":"\u003cp\u003eMethylation of arsenic is conversion from product to substrate \u003csup\u003e[39,40]\u003c/sup\u003e. The ratio of MAs/iAs is the primary methylation index, while the ratio of DMAs/MAs is the secondary methylation index (SMI). The SMI is primarily used to assess methylation capability in persons exposed to inorganic arsenic. \u003csup\u003e[41]\u003c/sup\u003e. We evaluated the methylation index of wild-type hAS3MT to that of eight polymorphic enzymes in this work. SMI and PMI were found to be lower in eight polymorphic enzymes. The greatest value of the DMAs/MAs ratio in wild-type enzymes is 2.3 0.3. M287T, R251H, and T306I SMI values (about 1.2) were lower than the wild-type enzyme but higher than the other SNPs, while the SMI values of H51R, I136T, and R173W enzymes were roughly 0.45. This research demonstrates that the eight non-synonymous missense variations of hAS3MT had a decreased arsenic methylation capacity when compared, implying that there is variance in arsenic methylation from individual to individual, which may raise the risk of arsenic-related disorders.\u0026nbsp;\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eThe gene-gene interactions As3MT*GSTM1 and GSTO2*GSTP1 were discovered to be possible regulators of urinary arsenic metabolites, increasing MMA and decreasing DMA, in this work. A synergistic effect of these polymorphisms and age, LADD of arsenic, and alcohol use may also alter a significant fraction of the population\u0026apos;s arsenic individual metabolic capacity. Despite some discrepancies between genotypes and metabolism in human case studies, we discovered that two SNPs, AS3MT 12390 (rs3740393) in intron and 14458 (rs11191439, Met287Thr) in exon, vary across all nations, indicating that SNPs may be ethnically independent polymorphisms, but they can affect arsenic methylation. Argentina\u0026apos;s population has a more proportion of DMA and a lower DM. This different distribution may have led to the findings that Argentina\u0026apos;s population had a higher percentage of DMA and a lower percentage of MMA in the urine when compared to other research. It\u0026apos;s worth looking into if the genotype distribution of AS3MT 12390 (rs3740393) is unique to this group (Argentinean Andes) and how this unique SNP selection happened.\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cp\u003eAS3MT \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- As\u003csup\u003eIII\u003c/sup\u003e SAM methyltransferase\u003c/p\u003e\n\u003cp\u003eAs\u003csup\u003eIII\u003c/sup\u003e\u0026nbsp; \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Arsenite\u003c/p\u003e\n\u003cp\u003eDMAs\u003csup\u003eIII\u003c/sup\u003e \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Dimethylarsenite\u003c/p\u003e\n\u003cp\u003eDMAs\u003csup\u003eV\u003c/sup\u003e \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Dimethylarsenate\u003c/p\u003e\n\u003cp\u003eESP \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Exome Sequencing Project\u003c/p\u003e\n\u003cp\u003eGSH \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Reduced glutathione\u003c/p\u003e\n\u003cp\u003eLB Medium \u0026nbsp; \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Luria\u0026ndash;Bertani medium\u003c/p\u003e\n\u003cp\u003eVNTR\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;- Variable Number of Tandem Repeats\u003c/p\u003e\n\u003cp\u003eMAs\u003csup\u003eIII\u003c/sup\u003e \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Methylarsenite\u003c/p\u003e\n\u003cp\u003eMAs\u003csup\u003eV\u003c/sup\u003e \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Methylarsenate\u003c/p\u003e\n\u003cp\u003eSAM \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- S-adenosylmethionine\u003c/p\u003e\n\u003cp\u003eSAH \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- S-adenosylhomocysteine\u003c/p\u003e\n\u003cp\u003eSNPs \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Single nucleotide polymorphisms\u003c/p\u003e\n\u003cp\u003eSMI \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Secondary methylation index\u003c/p\u003e\n\u003cp\u003eTMAs\u003csup\u003eIII\u003c/sup\u003e \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;-Trimethylarsine\u003c/p\u003e\n\u003cp\u003eTrx \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp;\u0026nbsp;- Thioredoxin\u003c/p\u003e\n\u003cp\u003eTR \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; \u0026nbsp; - Thioredoxin reductase\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe thank Prof. Mayur Bhosale for assistance with genetics, and Dr. Sanjay Bhawar, Principal, Pravara Rural College Of Pharmacy, Pravaranagar for comments that greatly improved the manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding Info\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;The authors have no relevant financial or non-financial interests to disclose.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEthics statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;This is an observational study. The Pravara Research Ethics Committee has confirmed that no ethical approval is required.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent to Participate (Ethics)\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eInformed consent was obtained from all individual participants included in the study\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent to Publish (Ethics)\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe participant has consented to the submission of the case report to the journal.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthor Contributions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u0026ldquo;All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Pratik V. Malvade, Mayur S. Bhosale, and Sayli R. Chavan. The first draft of the manuscript was written by Pratik V. Malvade and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAvailability of data and material\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe do not wish to share our data before we have thoroughly analyzed it. All data sources described in the study are directed at the corresponding author.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData Availability Statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis article is a review article. So, data sharing not applicable to this article as no datasets were generated or analyzed during the current study\u003cstrong\u003e\u003cu\u003e\u0026nbsp;\u003c/u\u003e\u003c/strong\u003e\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n \u003cli\u003eMelnick JG, Parkin G. Cleaving mercury-alkyl bonds: a functional model for mercury detoxification by MerB. Science. 2007; 317: 225\u0026ndash;227.\u0026nbsp;\u003ca href=\"https://doi.org/10.1126/science.1144314\"\u003ehttps://doi.org/10.1126/science.1144314\u003c/a\u003e\u0026nbsp; PMID: 17626880\u003c/li\u003e\n \u003cli\u003eHanikenne M, Talke IN, Haydon MJ, Lanz C, Nolte A, Motte P, et al. Evolution of metal hyperaccumulation required cis-regulatory changes and triplication of HMA4. Nature. 2008; 453: 391\u0026ndash;395.\u0026nbsp;\u003ca href=\"https://doi.org/10.1038/nature06877\"\u003ehttps://doi.org/10.1038/nature06877\u003c/a\u003e\u0026nbsp; PMID: 18425111\u003c/li\u003e\n \u003cli\u003eNajarro MA, Hackett JL, Smith BR, Highfill CA, King EG, Long AD, et al. Identifying loci contributing to natural variation in xenobiotic resistance in Drosophila. PLoS Genet. 2015; 11: e1005663.\u0026nbsp;\u003ca href=\"https://doi.org/10.1371/journal.pgen.1005663\"\u003ehttps://doi.org/10.1371/journal.pgen.1005663\u003c/a\u003e PMID: 26619284\u003c/li\u003e\n \u003cli\u003eRichard Grey, Dailymail.\u0026nbsp;\u003ca href=\"https://www.dailymail.co.uk/sciencetech/article-2979234/The-people-eat-ARSENIC-Remote-village-Andes-developed-tolerence-toxic-chemical.html\"\u003ehttps://www.dailymail.co.uk/sciencetech/article-2979234/The-people-eat-ARSENIC-Remote-village-Andes-developed-tolerence-toxic-chemical.html\u003c/a\u003e\u0026nbsp;\u003c/li\u003e\n \u003cli\u003eCaceres, D.D.; Pino, P.; Montesinos, N.; Atalah, E.; Amigo, H.; Loomis, D. Exposure to inorganic arsenic in drinking water and total urinary arsenic concentration in a Chilean population. Environ. Res. 2005, 98, 151\u0026ndash;159\u003c/li\u003e\n \u003cli\u003eCaceres, D.D.; Werlinger, F.; Orellana, M.; Jara, M.; Rocha, R.; Alvarado, S.; Qui\u0026ntilde;ones, L. Polymorphism of Glutathione S-Transferase (GST) variants and its effect on the distribution of urinary arsenic species in people exposed to low inorganic arsenic in tap water: An exploratory study. Arch. Environ. Occup. Health 2010, 65, 140\u0026ndash;147.\u003c/li\u003e\n \u003cli\u003eIARC (International Agency for Research on Cancer). Some drinking-water disinfectants and contaminants, including arsenic, IARC. Monogr. Eval. Carcinog. Risks Hum. 2004, 84, 1\u0026ndash;477.\u003c/li\u003e\n \u003cli\u003eWHO (World Health Organization). Arsenic in Drinking-water: Background document for development of WHO Guidelines for Drinking-water Quality; WHO Press, World Health Organization: Geneva, Switzerland, 2011\u003c/li\u003e\n \u003cli\u003eWu, M.M.; Kuo, T.L.; Hwang, Y.H.; Chen, C.J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 1989, 130, 1123\u0026ndash;1132.\u003c/li\u003e\n \u003cli\u003eTondel, M.; Rahman, M.; Magnuson, A.; Chowdhury, I.A.; Faruquee, M.H.; Ahmad, S.A. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ. Health Perspect. 1999, 107, 727\u0026ndash;729\u003c/li\u003e\n \u003cli\u003eThomas D. J., and Rosen B. P. (2013) Arsenic methyltransferases, in Encyclopedia of Metalloproteins (Kretsinger R. H., Uversky V. N., and Permyakov E. A., Eds.) pp 138\u0026minus;143, Springer New York, New York.\u003c/li\u003e\n \u003cli\u003eZhu Y. G.; Yoshinaga M.; Zhao F. J.; Rosen B. P. (2014) Earth abides arsenic biotransformations. Annu. Rev. Earth Planet. Sci. 42, 443\u0026ndash;467. 10.1146/annurev-earth-060313-054942.\u003c/li\u003e\n \u003cli\u003eTseng, C.H. Arsenic methylation, urinary arsenic metabolites, and human diseases: Current perspective. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 2007, 25, 1\u0026ndash;22.\u003c/li\u003e\n \u003cli\u003eAntonelli R.; Shao K.; Thomas D. J.; Sams R. 2nd; Cowden J. (2014) AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility. Environ. Res. 132, 156\u0026ndash;167. 10.1016/j.envres.2014.03.012\u003c/li\u003e\n \u003cli\u003eVahter M. (2002) Mechanisms of arsenic biotransformation. Toxicology 181-182, 211\u0026ndash;217. 10.1016/S0300-483X(02)00285-8.\u003c/li\u003e\n \u003cli\u003eValenzuela O. L.; Drobna Z.; Hernandez-Castellanos E.; Sanchez-Pena L. C.; Garcia-Vargas G. G.; Borja-Aburto V. H.; Styblo M.; Del Razo L. M. (2009) Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol. Appl. Pharmacol. 239, 200\u0026ndash;207. 10.1016/j.taap.2009.06.007\u003c/li\u003e\n \u003cli\u003eDe Chaudhuri, S.; Ghosh, P.; Sarma, N.; Majumdar, P.; Sau, T.J.; Basu, S.; Roychoudhury, S.; Ray, K.; Giri, A.K. Genetic variants associated with arsenic susceptibility: Study of purine nucleoside phosphorylase, arsenic (+ 3) methyltransferase, and glutathione S-transferase omega genes. Environ. Health Perspect. 2008\u003c/li\u003e\n \u003cli\u003eNaranmandura H, Chen X, Tanaka M, Wang WW, Rehman K, Xu S, et al. Release of apoptotic cytochrome C from mitochondria by dimethylarsinous acid occurs through interaction with voltage-dependent anion channel in vitro. Toxicol Sci. 2012; 128: 137\u0026ndash;146. (\u003ca href=\"https://doi.org/10.1093/toxsci/kfs154\"\u003ehttps://doi.org/10.1093/toxsci/kfs154\u003c/a\u003e)\u0026nbsp;\u0026nbsp;\u003c/li\u003e\n \u003cli\u003eDheeman D. S.; Packianathan C.; Pillai J. K.; Rosen B. P. (2014) Pathway of human AS3MT arsenic methylation. Chem. Res. Toxicol. 27, 1979\u0026ndash;1989. 10.1021/tx500313k\u003c/li\u003e\n \u003cli\u003eChen J.; Sun S.; Li C. Z.; Zhu Y. G.; Rosen B. P. (2014) Biosensor for organoarsenic herbicides and growth promoters. Environ. Sci. Technol. 48, 1141\u0026ndash;1147. 10.1021/es4038319\u003c/li\u003e\n \u003cli\u003eMarapakala K.; Qin J.; Rosen B. P. (2012) Identification of catalytic residues in the As(III) S-adenosylmethionine methyltransferase. Biochemistry 51, 944\u0026ndash;951. 10.1021/bi201500c.\u003c/li\u003e\n \u003cli\u003eWood, T. C., Salavagionne, O. E., Mukherjee, B., Wang, L., Klumpp, A. F., Thomae, B. A., Eckloff, B. W., Schaid, D. J., Wieben, E. D., and Weinshilboum, R. M. (2006) Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. J. Biol. Chem. 281, 7364\u0026minus;7373.\u003c/li\u003e\n \u003cli\u003eSambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular cloning, a laboratory manual, Cold Spring Harbor Laboratory, New York\u003c/li\u003e\n \u003cli\u003eCullen, W.R.; Reimer, K.J. Arsenic speciation in the environment. Chem. Rev. 1989, 89, 713\u0026ndash;764.\u003c/li\u003e\n \u003cli\u003ePetrick, J.S.; Ayala-Fierro, F.; Cullen, W.R.; Carter, D.E.; Vasken Aposhian, H. Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163, 203\u0026ndash;207\u003c/li\u003e\n \u003cli\u003eHayakawa, T.; Kobayashi, Y.; Cui, X.; Hirano, S. A new metabolic pathway of arsenite: Arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch. Toxicol. 2005, 79, 183\u0026ndash;191.\u003c/li\u003e\n \u003cli\u003eNaranmandura, H.; Suzuki, N.; Suzuki, K.T. Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 2006, 19, 1010\u0026ndash;1018.\u003c/li\u003e\n \u003cli\u003eWood, T.C.; Salavagionne, O.E.; Mukherjee, B.; Wang, L.W.; Klumpp, A.F.; Thomae, B.A.; Eckloff, B.W.; Schaid, D.J.; Wieben, E.D.; Weinshilboum, R.M. Human arsenic methyltransferase (AS3MT) pharmacogenetics\u0026mdash;Gene resequencing and functional genomics studies. J. Bio. Chem. 2006, 281, 7364\u0026ndash;7373\u003c/li\u003e\n \u003cli\u003eNCBI Reference Assembly; National Center for Biotechnology Information: Bethesda, MD, USA, 2010. Available online: http://www.ncbi.nlm.nih.gov/projects/SNP/ (accessed on 10 March 2011).\u003c/li\u003e\n \u003cli\u003eDong H.; Xu W.; Pillai J. K.; Packianathan C.; Rosen B. P. (2015) High-throughput screening-compatible assays of As(III) S-adenosylmethionine methyltransferase activity. Anal. Biochem. 480, 67\u0026ndash;73. 10.1016/j.ab.2015.04.011\u003c/li\u003e\n \u003cli\u003eGill S. C.; von Hippel P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319\u0026ndash;326. 10.1016/0003-2697(89)90602-7\u003c/li\u003e\n \u003cli\u003eAjees A. A.; Marapakala K.; Packianathan C.; Sankaran B.; Rosen B. P. (2012) Structure of an As(III) S-adenosylmethionine methyltransferase: insights into the mechanism of arsenic biotransformation. Biochemistry 51, 5476\u0026ndash;5485. 10.1021/bi3004632.\u003c/li\u003e\n \u003cli\u003eTseng, C.H. A review on environmental factors regulating arsenic methylation in humans. Toxicol. Appl. Pharm. 2009, 235, 338\u0026ndash;350\u003c/li\u003e\n \u003cli\u003eGonz\u0026aacute;lez-Mart\u0026iacute;nez, F.; S\u0026aacute;nchez-Rodas, D.; C\u0026aacute;ceres, D.; Mart\u0026iacute;nez, M.; Qui\u0026ntilde;ones, L.; Johnson-Restrepo, B. Arsenic exposure, profiles of urinary arsenic species, and polymorphism effects of glutathione-s-transferase and metallothioneins. Chemosphere 2018, 212, 927\u0026ndash;936\u003c/li\u003e\n \u003cli\u003eMarchiset, N.; Savanovitch, C.; Sauvant, P. What is the best biomarker to assess arsenic exposure via drinking water? Environ. Int. 2012, 39.\u003c/li\u003e\n \u003cli\u003eMeza, M.M.; Kopplin, M.J.; Burgess, J.L.; Gandolfi, A.J. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico. Environ. Res. 2004, 96, 119\u0026ndash;126.\u003c/li\u003e\n \u003cli\u003eHern\u0026aacute;ndez, A.; Xamena, N.; Sekaran, C.; Tokunaga, H.; Sampayo-Reyes, A.; Quinteros, D.; Creus, A.; Marcos, R. High arsenic metabolic efficiency in AS3MT287Thr allele carriers. Pharm. Genom. 2008, 18, 349\u0026ndash;355.\u003c/li\u003e\n \u003cli\u003eLesseur, C.; Diamond, D.G.; Andrew, A.S.; Ekstrom, R.M.; Li, Z.; Kelsey, K.T.; Marsit, C.J.; Karagas, M.R. A case-control study of polymorphisms in xenobiotic and arsenic metabolism Genes and arsenic-related bladder cancer in New Hampshire. Toxicol. Lett. 2012, 210, 100\u0026ndash;106.\u003c/li\u003e\n \u003cli\u003eHuang J. H.; Scherr F.; Matzner E. (2007) Demethylation of dimethylarsinic acid and arsenobetaine in different organic soils. Water, Air, Soil Pollut. 182, 31\u0026ndash;41. 10.1007/s11270-006-9318-4.\u003c/li\u003e\n \u003cli\u003eHuang Y. L.; Hsueh Y. M.; Huang Y. K.; Yip P. K.; Yang M. H.; Chen C. J. (2009) Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Sci. Total Environ. 407, 2608\u0026ndash;2614. 10.1016/j.scitotenv.2008.12.061\u003c/li\u003e\n \u003cli\u003eChen G. Q.; Zhou L.; Styblo M.; Walton F.; Jing Y.; Weinberg R.; Chen Z.; Waxman S. (2003) Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukaemia and lymphoma cells. Cancer Res. 63, 1853\u0026ndash;1859.\u003c/li\u003e\n \u003cli\u003eAbernathy, C. O., Calderon, R. L., and Chappell, W. (1997) Arsenic: Exposure and Health Effects, Chapman \u0026amp; Hall, London\u003c/li\u003e\n \u003cli\u003eSanz, M. A., Fenaux, P., Lo Coco, F., and European APL Group of Experts (2005) Haematologica 90, 1231\u0026ndash;1235\u003c/li\u003e\n \u003cli\u003eWang, L., Sullivan, W., Toft, D., and Weinshilboum, R. (2003) Pharmacogenetics 13, 555\u0026ndash;564\u003c/li\u003e\n \u003cli\u003eThomae, B. A., Rifki, O. F., Theobald, M. A., Eckloff, B. W., Wieben, E. D., and Weinshilboum, R. M. (2003) J. Neurochem. 87, 809\u0026ndash;819\u003c/li\u003e\n \u003cli\u003eShield, A. J., Thomae, B. A., Eckloff, B. W., Wieben, E. D., and Weinshilboum, R. M. (2004) Mol. Psychiatr. 9, 151\u0026ndash;160\u003c/li\u003e\n \u003cli\u003e. Agusa T.; Fujihara J.; Takeshita H.; Iwata H. (2011) Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int. J. Mol. Sci. 12, 2351\u0026ndash;2382. 10.3390/ijms12042351.\u003c/li\u003e\n \u003cli\u003eDong H.; Madegowda M.; Nefzi A.; Houghten R. A.; Giulianotti M. A.; Rosen B. P. (2015) Identification of small molecule inhibitors of human As(III) S-adenosylmethionine methyltransferase (AS3MT). Chem. Res. Toxicol. 28, 2419\u0026ndash;2425. 10.1021/acs.chemrestox.5b00432.\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Genetic Mutation, Arsenic Metabolism, AS3MT, MAsIII, DMAsIII","lastPublishedDoi":"10.21203/rs.3.rs-1320965/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-1320965/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"The AS3MT may be a most significant protein for the methylation of chemical elements species. The transfer of methyl radical from S-adenosyl-L-methionine (AdoMet) to powerfulness arsenical (AsIII) is catalyzed by the AS3MT that is critical for arsenic metabolism in humans. Since genetic polymorphisam of AS3MT is related to arsenic tolerance, here investigate co-relationship in between single ester polymorphisms (SNPs) in AS3MT with inorganic arsenic (iAs) metabolism. additionally we tend to compared chemical action properties of recombinant human AS3MT and AS3MT/M287T in reaction mixtures containing S-adenosylmethionine, arsenite (iAsIII) or methylarsonous acid (MAsIII) as substrates and endogenous reductants, together with glutathione (GSH), a thioredoxin enzyme (TR) or thioredoxin (Trx) or NADPH reducing system and tris(2-carboxyethyl) pesticide complex (TCEP). By victimisation of either TR or Trx or NADPH or TCEP, AS3MT catalyzes the conversion of iAsIII to MAsIII then to methyl radicalarsonic acid (MAsV), dimethylarsinous acid (DMAsIII) and di ethylarsinic acid (DMAsV). The Cys156 and Cys206 gift in similarity model forms the binding website for AsIII. Cys32 and Cys61 forms a disulphide bond. the most important product in initiative of methylation is MAsIII that remains sure to protein until it get methylated. The product are the a lot of hepatotoxic and more malignant neoplastic disease powerfulness methyl arsenicals, however arsenic undergoes oxidisation and reduction as enzyme-bound intermediates.","manuscriptTitle":"Metabolism of Arsenic in Human by AS3MT Gene","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2022-07-25 19:01:21","doi":"10.21203/rs.3.rs-1320965/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"f76e6a68-f0fb-470e-9b2c-ecc44bd967dd","owner":[],"postedDate":"July 25th, 2022","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2022-07-25T19:01:21+00:00","versionOfRecord":[],"versionCreatedAt":"2022-07-25 19:01:21","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-1320965","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-1320965","identity":"rs-1320965","version":["v1"]},"buildId":"WrCJVZZCHTDjtuVLN7oU0","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}